Hain Celestial Reports Fiscal First Quarter 2025 Financial Results
“Our performance in the first quarter built upon the momentum from our foundational year by further streamlining our portfolio and operational footprint, enabling us to deliver gross margin expansion,” said
FINANCIAL HIGHLIGHTS*
Summary of Fiscal First Quarter Results Compared to the Prior Year Period
- Net sales were
$395 million , down 7% year-over-year.- Organic net sales, defined as net sales adjusted to exclude the impact of foreign exchange, acquisitions, divestitures, discontinued brands and exited product categories, decreased 5% compared to the prior year period.
- The decrease in organic net sales was comprised of a 4-point decrease in volume/mix and a 1-point decrease in price.
- Organic net sales, defined as net sales adjusted to exclude the impact of foreign exchange, acquisitions, divestitures, discontinued brands and exited product categories, decreased 5% compared to the prior year period.
- Gross profit margin was 20.7%, a 90-basis point increase from the prior year period.
- Adjusted gross profit margin was 20.8%, a 20-basis point increase from the prior year period.
- Net loss was
$20 million compared to net loss of$10 million in the prior year period.- Adjusted net loss was
$4 million , flat compared to the prior year period.
- Adjusted net loss was
- Net loss margin was (5.0%), as compared to net loss margin of (2.4%) in the prior year period.
- Adjusted net loss margin was (1.0%), as compared to adjusted net loss margin of (0.8%) in the prior year period.
- Adjusted EBITDA was
$22 million compared to$24 million in the prior year period; Adjusted EBITDA margin was 5.7%, in line with the prior year period. - Loss per diluted share was
$0.22 compared to$0.12 in the prior year period.- Adjusted loss per share was
$0.04 compared to$0.04 in the prior year period.
- Adjusted loss per share was
Cash Flow and Balance Sheet Highlights
- Net cash used in operating activities in the fiscal first quarter was
($11) million compared to net cash provided by operating activities of$14 million in the prior year period. - Free cash flow was negative
($17) million in the fiscal first quarter compared to free cash flow of$7 million in the prior year period. - Total debt at the end of the fiscal first quarter was
$740 million down from$744 million at the beginning of the fiscal year. - Net debt at the end of the fiscal first quarter was
$684 million compared to$690 million at the beginning of the fiscal year. - The company ended the first quarter with a net secured leverage ratio of 3.9x as calculated under our amended credit agreement.
SEGMENT HIGHLIGHTS
The company operates under two reportable segments:
Quarter Ended |
|||||||||
$ Millions | Reported Growth Y/Y |
M&A/Exit Impact1 | FX Impact | Organic Growth Y/Y |
|||||
231 | -11 | % | -4 | % | 0 | % | -6 | % | |
International | 163 | -1 | % | 0 | % | 2 | % | -3 | % |
Total | 395 | -7 | % | -3 | % | 1 | % | -5 | % |
* May not add due to rounding 1 Reflects the impact within reported net sales growth of the following items that are excluded from organic net sales growth: net sales from divested brands (ParmCrisps® and Thinsters® snacks brands and Queen Helene® personal care brand), discontinued brands, and exited product categories. |
|||||||||
The fiscal first quarter organic net sales decrease was 6% year-over-year, driven primarily by lower sales in snacks, as expected, due to the timing shift of a promotional event from the fiscal 1st quarter in 2024 into the fiscal 3rd quarter this year, as well as lower sales in meal prep, partially offset by growth in beverages.
Segment gross profit in the fiscal first quarter was
Adjusted EBITDA in the fiscal first quarter was
International
The fiscal first quarter organic net sales decline was 3% year-over-year, due primarily to lower sales in meal prep and baby & kids.
Segment gross profit in the fiscal first quarter was
Adjusted EBITDA in the fiscal first quarter was
CATEGORY HIGHLIGHTS
Quarter Ended |
|||||||||
$ Millions | Reported Growth Y/Y |
M&A/Exit Impact1 | FX Impact | Organic Growth Y/Y |
|||||
Snacks | 99 | -15 | % | -6 | % | 0 | % | -9 | % |
Baby & Kids | 61 | -3 | % | -1 | % | 1 | % | -3 | % |
Beverages | 57 | 1 | % | 0 | % | 1 | % | 0 | % |
159 | -4 | % | 0 | % | 1 | % | -5 | % | |
Personal Care | 18 | -24 | % | -13 | % | -1 | % | -11 | % |
Total | 395 | -7 | % | -3 | % | 1 | % | -5 | % |
* May not add due to rounding 1 Reflects the impact within reported net sales growth of the following items that are excluded from organic net sales growth: net sales from divested brands (ParmCrisps® and Thinsters® snacks brands and Queen Helene® personal care brand), discontinued brands, and exited product categories. |
|||||||||
Snacks
The fiscal first quarter organic net sales decline of 9% year-over-year was driven by the timing shift of a promotional event that was held in the first quarter last fiscal year into the third quarter this fiscal year, as expected.
Baby & Kids
The fiscal first quarter organic net sales decline of 3% year-over-year represented an improvement from the fiscal fourth quarter year-over-year decline of 10%. The decline in net sales was partially offset by growth in Earth’s Best® snacks.
Beverages
Fiscal first quarter organic net sales were flat year-over-year, as growth in tea and private label non-dairy beverage were offset by branded non-dairy beverage.
The fiscal first quarter organic net sales decline of 5% year-over-year was driven primarily by short-term softness in private label spreads & drizzles, declines in yogurt as we cycle a customer shift to private label, and meat-free. The decline was partially offset by continued strong growth in the soup brands in the UK.
Personal Care
The fiscal first quarter organic net sales decline was 11% year-over-year, an improvement from the fiscal fourth quarter year-over-year decline of 16%. The decline in the quarter was driven primarily by the impact of portfolio simplification as we continue to focus on the execution of our stabilization plan.
FISCAL 2025 GUIDANCE*
“We have a number of known tailwinds in the back half of the fiscal year which give us confidence in our plan to pivot to growth in fiscal 2025. We expect productivity to accelerate in the back half and we have the right initiatives in place to drive both margin expansion and net working capital improvements which will enable us to continue to reduce net debt and improve our leverage. We are pleased to reaffirm our fiscal 2025 guidance,” stated
The company is reaffirming guidance for fiscal 2025:
- Organic net sales growth is expected to be flat or better.
- Adjusted EBITDA is expected to grow by mid-single digits.
- Gross margin is expected to increase by at least 125 basis points.
- Free cash flow is expected to be at least
$60 million .
* The forward-looking non-GAAP financial measures included in this section are not reconciled to the comparable forward-looking GAAP financial measures. The company is not able to reconcile these forward-looking non-GAAP financial measures to their most directly comparable forward-looking GAAP financial measures without unreasonable efforts because the company is unable to predict with a reasonable degree of certainty the type and extent of certain items that would be expected to impact GAAP measures but would not impact the non-GAAP measures. Such items may include certain litigation and related expenses, transaction costs associated with acquisitions and divestitures, productivity and transformation costs, impairments, gains or losses on sales of assets and businesses, foreign exchange movements and other items. The unavailable information could have a significant impact on the company’s GAAP financial results.
Conference Call and Webcast Information
About
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward-looking statements. The words “believe,” “expect,” “anticipate,” “may,” “should,” “plan,” “intend,” “potential,” “will” and similar expressions are intended to identify such forward-looking statements. Forward-looking statements include, among other things: our beliefs or expectations relating to our future performance, results of operations and financial condition, including statements related to our ability to expand margins, improve net working capital, reduce debt and improve leverage; our strategic initiatives and business strategy, including statements related to Hain Reimagined and our Hain Reimagined goals; our supply of products contracted for with our contract manufacturers, including infant formula; our supply chain, including the availability and pricing of raw materials; our productivity pipeline; our brand portfolio; and pricing actions and product performance.
Risks and uncertainties that may cause actual results to differ materially from forward-looking statements include: challenges and uncertainty resulting from the impact of competition; our ability to manage our supply chain effectively; input cost inflation, including with respect to freight and other distribution costs; disruption of operations at our manufacturing facilities; reliance on independent contract manufacturers; changes to consumer preferences; customer concentration; our ability to execute our cost reduction initiatives and related strategic initiatives; reliance on independent distributors; risks associated with operating internationally; the availability of organic ingredients; risks associated with outsourcing arrangements; risks associated with geopolitical conflicts or events; our ability to identify and complete acquisitions or divestitures and our level of success in integrating acquisitions; our reliance on independent certification for a number of our products; our ability to attract and retain highly skilled people; risks related to tax matters; impairments in the carrying value of goodwill or other intangible assets; the reputation of our company and our brands; our ability to use and protect trademarks; foreign currency exchange risk; general economic conditions; compliance with our credit agreement; cybersecurity incidents; disruptions to information technology systems; the impact of climate change and related disclosure regulations; liabilities, claims or regulatory change with respect to environmental matters; pending and future litigation, including litigation relating to Earth’s Best® baby food products; potential liability if our products cause illness or physical harm; the highly regulated environment in which we operate; compliance with data privacy laws; the adequacy of our insurance coverage; and other risks and matters described in our most recent Annual Report on Form 10-K and our other filings from time to time with the
We undertake no obligation to update forward-looking statements to reflect actual results or changes in assumptions or circumstances, except as required by applicable law.
Non-GAAP Financial Measures
This press release and the accompanying tables include non-GAAP financial measures, including, among others, organic net sales, adjusted operating income and its related margin, adjusted gross profit and its related margin, adjusted net loss and its related margin, adjusted loss per diluted share, adjusted EBITDA and its related margin, free cash flow and net debt. The reconciliations of historic non-GAAP financial measures to the comparable GAAP financial measures are provided in the tables below. These non-GAAP financial measures should not be considered in isolation or as a substitute for the comparable GAAP measures. In addition, these non-GAAP measures may not be the same as similar measures provided by other companies due to potential differences in methods of calculation and items being excluded. They should be read only in connection with the company’s consolidated financial statements presented in accordance with GAAP.
We define our non-GAAP financial measures as follows:
- Organic net sales: net sales excluding the impact of acquisitions, divestitures, discontinued brands and exited product categories and foreign exchange. To adjust organic net sales for the impact of acquisitions, the net sales of an acquired business are excluded from fiscal quarters constituting or falling within the current period and prior period where the applicable fiscal quarter in the prior period did not include the acquired business for the entire quarter. To adjust organic net sales for the impact of divestitures, discontinued brands and exited product categories, the net sales of a divested business, discontinued brand or exited product category are excluded from all periods. To adjust organic net sales for the impact of foreign exchange, current period net sales for entities reporting in currencies other than the
U.S. dollar are translated intoU.S. dollars at the average monthly exchange rates in effect during the corresponding period of the prior fiscal year, rather than at the actual average monthly exchange rate in effect during the current period of the current fiscal year. - Adjusted gross profit and its related margin: gross profit, before plant closure related costs, net.
- Adjusted operating income and its related margin: operating income (loss) before certain litigation expenses, net, plant closure related costs, net, productivity and transformation costs, costs associated with acquisitions, divestitures and other transactions, and long-lived asset impairment.
- Adjusted net loss and its related margin and diluted net loss per common share, as adjusted: net loss, adjusted to exclude the impact of certain litigation expenses, net, plant closure related costs, net, productivity and transformation costs, costs associated with acquisitions, divestitures and other transactions, losses on sales of assets, long-lived asset impairment, unrealized currency losses (gains) and the related tax effects of such adjustments, and other costs.
- Adjusted EBITDA: net loss before net interest expense, income taxes, depreciation and amortization, equity in net loss of equity-method investees, stock-based compensation, net, unrealized currency losses, certain litigation and related costs, plant closure related costs, net, productivity and transformation costs, costs associated with acquisitions, divestitures and other transactions, losses on sales of assets, transaction and integration costs, net, long-lived asset impairment and other adjustments.
- Free cash flow: net cash (used in) provided by operating activities less purchases of property, plant and equipment.
- Net debt: total debt less cash and cash equivalents.
We believe that the non-GAAP financial measures presented provide useful additional information to investors about current trends in the company’s operations and are useful for period-over-period comparisons of operations. We provide:
- Organic net sales to demonstrate the growth rate of net sales excluding the impact of acquisitions, divestitures, discontinued brands, and exited product categories and foreign exchange, and believe organic net sales is useful to investors because it enables them to better understand the growth of our business from period to period.
- Adjusted results as important supplemental measures of our performance and believe they are frequently used by securities analysts, investors and other interested parties in the evaluation of our Company and companies in our industry.
- Free cash flow as one factor in evaluating the amount of cash available for discretionary investments.
- Net debt as a useful measure to monitor leverage and evaluate the balance sheet.
We discuss the Company’s net secured leverage ratio as calculated under our credit agreement as a measure of our financial condition, liquidity and compliance with our credit agreement. For a description of the material terms of our credit agreement and risks of non-compliance with our credit agreement, see “Liquidity and Capital Resources” under “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” in our most recent Annual Report on Form 10-K and our subsequent quarterly reports on Form 10-Q filed with the
Investor Relations Contact:
Investor.Relations@hain.com
Media Contact:
Jen.Davis@hain.com
Consolidated Statements of Operations | |||||||
(unaudited and in thousands, except per share amounts) | |||||||
First Quarter | |||||||
2025 | 2024 | ||||||
Net sales | $ | 394,596 | $ | 425,029 | |||
Cost of sales | 312,986 | 341,086 | |||||
Gross profit | 81,610 | 83,943 | |||||
Selling, general and administrative expenses | 71,328 | 77,169 | |||||
Productivity and transformation costs | 5,018 | 6,403 | |||||
Amortization of acquired intangible assets | 2,180 | 1,955 | |||||
Long-lived asset impairment | 31 | 694 | |||||
Operating income (loss) | 3,053 | (2,278 | ) | ||||
Interest and other financing expense, net | 13,746 | 13,244 | |||||
Other expense (income), net | 5,292 | (265 | ) | ||||
Loss before income taxes and equity in net loss of equity-method investees | (15,985 | ) | (15,257 | ) | |||
Provision (benefit) for income taxes | 3,523 | (5,379 | ) | ||||
Equity in net loss of equity-method investees | 155 | 498 | |||||
Net loss | $ | (19,663 | ) | $ | (10,376 | ) | |
Net loss per common share: | |||||||
Basic | $ | (0.22 | ) | $ | (0.12 | ) | |
Diluted | $ | (0.22 | ) | $ | (0.12 | ) | |
Shares used in the calculation of net loss per common share: | |||||||
Basic | 89,861 | 89,512 | |||||
Diluted | 89,861 | 89,512 | |||||
Consolidated Balance Sheets | |||||||
(unaudited and in thousands) | |||||||
ASSETS | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 56,853 | $ | 54,307 | |||
Accounts receivable, net | 188,190 | 179,190 | |||||
Inventories | 270,418 | 274,128 | |||||
Prepaid expenses and other current assets | 48,570 | 49,434 | |||||
Total current assets | 564,031 | 557,059 | |||||
Property, plant and equipment, net | 266,947 | 261,730 | |||||
936,341 | 929,304 | ||||||
Trademarks and other intangible assets, net | 250,179 | 244,799 | |||||
Investments and joint ventures | 10,080 | 10,228 | |||||
Operating lease right-of-use assets, net | 85,029 | 86,634 | |||||
Other assets | 22,202 | 27,794 | |||||
Total assets | $ | 2,134,809 | $ | 2,117,548 | |||
LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||
Current liabilities: | |||||||
Accounts payable | $ | 184,969 | $ | 188,220 | |||
Accrued expenses and other current liabilities | 88,160 | 85,714 | |||||
Current portion of long-term debt | 7,567 | 7,569 | |||||
Total current liabilities | 280,696 | 281,503 | |||||
Long-term debt, less current portion | 732,799 | 736,523 | |||||
Deferred income taxes | 45,397 | 47,826 | |||||
Operating lease liabilities, noncurrent portion | 78,905 | 80,863 | |||||
Other noncurrent liabilities | 33,351 | 27,920 | |||||
Total liabilities | 1,171,148 | 1,174,635 | |||||
Stockholders' equity: | |||||||
Common stock | 1,120 | 1,119 | |||||
Additional paid-in capital | 1,233,129 | 1,230,253 | |||||
Retained earnings | 557,856 | 577,519 | |||||
Accumulated other comprehensive loss | (99,409 | ) | (137,245 | ) | |||
1,692,696 | 1,671,646 | ||||||
Less: |
(729,035 | ) | (728,733 | ) | |||
Total stockholders' equity | 963,661 | 942,913 | |||||
Total liabilities and stockholders' equity | $ | 2,134,809 | $ | 2,117,548 | |||
Consolidated Statements of Cash Flows | |||||||
(unaudited and in thousands) | |||||||
First Quarter | |||||||
2025 | 2024 | ||||||
CASH FLOWS FROM OPERATING ACTIVITIES | |||||||
Net loss | $ | (19,663 | ) | $ | (10,376 | ) | |
Adjustments to reconcile net loss to net cash (used in) provided by operating activities | |||||||
Depreciation and amortization | 11,427 | 12,305 | |||||
Deferred income taxes | (671 | ) | (11,269 | ) | |||
Equity in net loss of equity-method investees | 155 | 498 | |||||
Stock-based compensation, net | 2,876 | 3,742 | |||||
Long-lived asset impairment | 31 | 694 | |||||
Loss on sale of assets | 3,934 | 62 | |||||
Other non-cash items, net | 1,085 | (556 | ) | ||||
(Decrease) increase in cash attributable to changes in operating assets and liabilities: | |||||||
Accounts receivable | (3,926 | ) | (1,150 | ) | |||
Inventories | 2,282 | (7,423 | ) | ||||
Other current assets | (2,471 | ) | 8,761 | ||||
Other assets and liabilities | 579 | (3,198 | ) | ||||
Accounts payable and accrued expenses | (6,425 | ) | 21,940 | ||||
Net cash (used in) provided by operating activities | (10,787 | ) | 14,030 | ||||
CASH FLOWS FROM INVESTING ACTIVITIES | |||||||
Purchases of property, plant and equipment | (5,757 | ) | (6,906 | ) | |||
Proceeds from sale of assets | 12,066 | 1,257 | |||||
Net cash provided by (used in) investing activities | 6,309 | (5,649 | ) | ||||
CASH FLOWS FROM FINANCING ACTIVITIES | |||||||
Borrowings under bank revolving credit facility | 59,000 | 46,000 | |||||
Repayments under bank revolving credit facility | (61,000 | ) | (57,000 | ) | |||
Repayments under term loan | (1,875 | ) | (1,875 | ) | |||
Payments of other debt, net | (21 | ) | (3,834 | ) | |||
Employee shares withheld for taxes | (302 | ) | (875 | ) | |||
Net cash used in financing activities | (4,198 | ) | (17,584 | ) | |||
Effect of exchange rate changes on cash | 11,222 | (5,881 | ) | ||||
Net increase (decrease) in cash and cash equivalents | 2,546 | (15,084 | ) | ||||
Cash and cash equivalents at beginning of period | 54,307 | 53,364 | |||||
Cash and cash equivalents at end of period | $ | 56,853 | $ | 38,280 | |||
(unaudited and in thousands) | |||||||||||||||
International | Corporate/Other | Hain Consolidated | |||||||||||||
Net sales - Q1 FY25 | $ | 231,140 | $ | 163,456 | $ | - | $ | 394,596 | |||||||
Net sales - Q1 FY24 | $ | 260,054 | $ | 164,975 | $ | - | $ | 425,029 | |||||||
% change - FY25 net sales vs. FY24 net sales | (11.1)% | (0.9)% | (7.2)% | ||||||||||||
Gross Profit | |||||||||||||||
Q1 FY25 | |||||||||||||||
Gross profit | $ | 47,284 | $ | 34,326 | $ | - | $ | 81,610 | |||||||
Non-GAAP adjustments(1) | 329 | - | - | 329 | |||||||||||
Adjusted gross profit | $ | 47,613 | $ | 34,326 | $ | - | $ | 81,939 | |||||||
% change - FY25 gross profit vs. FY24 gross profit | (7.1)% | 3.9% | (2.8)% | ||||||||||||
% change - FY25 adjusted gross profit vs. FY24 adjusted gross profit | (12.2)% | 3.9% | (6.1)% | ||||||||||||
Gross margin | 20.5% | 21.0% | 20.7% | ||||||||||||
Adjusted gross margin | 20.6% | 21.0% | 20.8% | ||||||||||||
Q1 FY24 | |||||||||||||||
Gross profit | $ | 50,896 | $ | 33,047 | $ | - | $ | 83,943 | |||||||
Non-GAAP adjustments(1) | 3,320 | - | - | 3,320 | |||||||||||
Adjusted gross profit | $ | 54,216 | $ | 33,047 | $ | - | $ | 87,263 | |||||||
Gross margin | 19.6% | 20.0% | 19.7% | ||||||||||||
Adjusted gross margin | 20.8% | 20.0% | 20.5% | ||||||||||||
Adjusted EBITDA | |||||||||||||||
Q1 FY25 | |||||||||||||||
Adjusted EBITDA | $ | 12,459 | $ | 20,370 | $ | (10,454 | ) | $ | 22,375 | ||||||
% change - FY25 adjusted EBITDA vs. FY24 adjusted EBITDA | (33.5)% | 16.8% | 13.4% | (7.1)% | |||||||||||
Adjusted EBITDA margin | 5.4% | 12.5% | 5.7% | ||||||||||||
Q1 FY24 | |||||||||||||||
Adjusted EBITDA | $ | 18,727 | $ | 17,438 | $ | (12,075 | ) | $ | 24,090 | ||||||
Adjusted EBITDA margin | 7.2% | 10.6% | 5.7% | ||||||||||||
(1) See accompanying table "Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Loss and Adjusted Loss per Diluted Share" |
Adjusted Gross Profit, Adjusted Operating Income, Adjusted Net Loss and Adjusted Loss per Diluted Share | |||||||
(unaudited and in thousands, except per share amounts) | |||||||
Reconciliation of Gross Profit, GAAP to Gross Profit, as Adjusted: | |||||||
First Quarter | |||||||
2025 | 2024 | ||||||
Gross profit, GAAP | $ | 81,610 | $ | 83,943 | |||
Adjustments to Cost of sales: | |||||||
Plant closure related costs, net | 329 | 3,320 | |||||
Gross profit, as adjusted | $ | 81,939 | $ | 87,263 | |||
Reconciliation of Operating Income (Loss), GAAP to Operating Income, as Adjusted: | |||||||
First Quarter | |||||||
2025 | 2024 | ||||||
Operating income (loss), GAAP | $ | 3,053 | $ | (2,278 | ) | ||
Adjustments to Cost of sales: | |||||||
Plant closure related costs, net | 329 | 3,320 | |||||
Adjustments to Operating expenses(a): | |||||||
Productivity and transformation costs | 5,018 | 6,403 | |||||
Certain litigation expenses, net(b) | 827 | 1,524 | |||||
Plant closure related costs, net | 47 | (53 | ) | ||||
Long-lived asset impairment | 31 | 694 | |||||
Transaction and integration costs, net | (318 | ) | 118 | ||||
Operating income, as adjusted | $ | 8,987 | $ | 9,728 | |||
Reconciliation of Net Loss, GAAP to Net Loss, as Adjusted: | |||||||
First Quarter | |||||||
2025 | 2024 | ||||||
Net loss, GAAP | $ | (19,663 | ) | $ | (10,376 | ) | |
Adjustments to Cost of sales: | |||||||
Plant closure related costs, net | 329 | 3,320 | |||||
Adjustments to Operating expenses(a): | |||||||
Productivity and transformation costs | 5,018 | 6,403 | |||||
Certain litigation expenses, net(b) | 827 | 1,524 | |||||
Plant closure related costs, net | 47 | (53 | ) | ||||
Long-lived asset impairment | 31 | 694 | |||||
Transaction and integration costs, net | (318 | ) | 118 | ||||
Adjustments to Interest and other expense, net(c): | |||||||
Loss on sale of assets | 3,934 | 62 | |||||
Unrealized currency losses (gains) | 1,194 | (796 | ) | ||||
Adjustments to Provision (benefit) for income taxes: | |||||||
Net tax impact of non-GAAP adjustments | 4,793 | (4,427 | ) | ||||
Net loss, as adjusted | $ | (3,808 | ) | $ | (3,531 | ) | |
Net loss margin | (5.0 | )% | (2.4 | )% | |||
Adjusted net loss margin | (1.0 | )% | (0.8 | )% | |||
Diluted shares used in the calculation of net loss per common share: | 89,861 | 89,512 | |||||
Diluted shares used in the calculation of adjusted net loss per common share: | 89,861 | 89,512 | |||||
Diluted net loss per common share, GAAP | $ | (0.22 | ) | $ | (0.12 | ) | |
Diluted net loss per common share, as adjusted | $ | (0.04 | ) | $ | (0.04 | ) | |
(a) Operating expenses include amortization of acquired intangibles, selling, general and administrative expenses, long-lived asset impairment and productivity and transformation costs. | |||||||
(b) Expenses and items relating to securities class action, baby food litigation and |
|||||||
(c) Interest and other expense, net includes interest and other financing expenses, net, unrealized currency losses (gains), loss on sale of assets and other expense, net. | |||||||
Organic Net Sales Growth by Segment | |||||||||||
(unaudited and in thousands) | |||||||||||
Q1 FY25 | International | Hain Consolidated | |||||||||
Net sales | $ | 231,140 | $ | 163,456 | $ | 394,596 | |||||
Less: Impact of divestitures, discontinued brands and exited product categories | 8,110 | 218 | 8,328 | ||||||||
Less: Impact of foreign currency exchange | (529 | ) | 3,835 | 3,306 | |||||||
Organic net sales | $ | 223,559 | $ | 159,403 | $ | 382,962 | |||||
Q1 FY24 | |||||||||||
Net sales | $ | 260,054 | $ | 164,975 | $ | 425,029 | |||||
Less: Impact of divestitures, discontinued brands and exited product categories | 20,973 | 476 | 21,449 | ||||||||
Organic net sales | $ | 239,081 | $ | 164,499 | $ | 403,580 | |||||
Net sales decline | (11.1)% | (0.9)% | (7.2)% | ||||||||
Less: Impact of divestitures, discontinued brands and exited product categories | (4.4)% | (0.1)% | (2.9)% | ||||||||
Less: Impact of foreign currency exchange | (0.2)% | 2.3% | 0.8% | ||||||||
Organic net sales decline | (6.5)% | (3.1)% | (5.1)% | ||||||||
Organic Net Sales Growth by Category | |||||||||||||||||||||||
(unaudited and in thousands) | |||||||||||||||||||||||
Q1 FY25 | Snacks | Baby & Kids | Beverages | Personal Care |
Hain Consolidated |
||||||||||||||||||
Net sales | $ | 99,475 | $ | 60,768 | $ | 56,676 | $ | 159,392 | $ | 18,285 | $ | 394,596 | |||||||||||
Less: Impact of divestitures, discontinued brands and exited product categories | 3,293 | 109 | - | 2,445 | 2,481 | 8,328 | |||||||||||||||||
Less: Impact of foreign currency exchange | (19 | ) | 710 | 309 | 2,403 | (97 | ) | 3,306 | |||||||||||||||
Organic net sales | $ | 96,201 | $ | 59,949 | $ | 56,367 | $ | 154,544 | $ | 15,901 | $ | 382,962 | |||||||||||
Q1 FY24 | |||||||||||||||||||||||
Net sales | $ | 117,088 | $ | 62,528 | $ | 56,148 | $ | 165,196 | $ | 24,069 | $ | 425,029 | |||||||||||
Less: Impact of divestitures, discontinued brands and exited product categories | 11,733 | 656 | - | 2,797 | 6,263 | 21,449 | |||||||||||||||||
Organic net sales | $ | 105,355 | $ | 61,872 | $ | 56,148 | $ | 162,399 | $ | 17,806 | $ | 403,580 | |||||||||||
Net sales (decline) growth | (15.0)% | (2.8)% | 0.9% | (3.5)% | (24.0)% | (7.2)% | |||||||||||||||||
Less: Impact of divestitures, discontinued brands and exited product categories | (6.3)% | (0.8)% | 0.0% | (0.2)% | (12.8)% | (2.9)% | |||||||||||||||||
Less: Impact of foreign currency exchange | (0.0)% | 1.1% | 0.5% | 1.5% | (0.5)% | 0.8% | |||||||||||||||||
Organic net sales (decline) growth | (8.7)% | (3.1)% | 0.4% | (4.8)% | (10.7)% | (5.1)% | |||||||||||||||||
Adjusted EBITDA | |||||||
(unaudited and in thousands) | |||||||
First Quarter | |||||||
2025 | 2024 | ||||||
Net loss | $ | (19,663 | ) | $ | (10,376 | ) | |
Depreciation and amortization | 11,427 | 12,305 | |||||
Equity in net loss of equity-method investees | 155 | 498 | |||||
Interest expense, net | 12,995 | 12,623 | |||||
Provision (benefit) for income taxes | 3,523 | (5,379 | ) | ||||
Stock-based compensation, net | 2,876 | 3,742 | |||||
Unrealized currency losses | 1,194 | 35 | |||||
Certain litigation expenses, net(a) | 827 | 1,524 | |||||
Restructuring activities | |||||||
Productivity and transformation costs | 5,018 | 6,403 | |||||
Plant closure related costs, net | 376 | 1,841 | |||||
Acquisitions, divestitures and other | |||||||
Loss on sale of assets | 3,934 | 62 | |||||
Transaction and integration costs, net | (318 | ) | 118 | ||||
Impairment charges | |||||||
Long-lived asset impairment | 31 | 694 | |||||
Adjusted EBITDA | $ | 22,375 | $ | 24,090 | |||
(a) Expenses and items relating to securities class action, baby food litigation and |
|||||||
Free Cash Flow | |||||||
(unaudited and in thousands) | |||||||
First Quarter | |||||||
2025 | 2024 | ||||||
Net cash (used in) provided by operating activities | $ | (10,787 | ) | $ | 14,030 | ||
Purchases of property, plant and equipment | (5,757 | ) | (6,906 | ) | |||
Free cash flow | $ | (16,544 | ) | $ | 7,124 | ||
Net Debt | |||||
(unaudited and in thousands) | |||||
Debt | |||||
Long-term debt, less current portion | $ | 732,799 | $ | 736,523 | |
Current portion of long-term debt | 7,567 | 7,569 | |||
Total debt | 740,366 | 744,092 | |||
Less: Cash and cash equivalents | 56,853 | 54,307 | |||
Net debt | $ | 683,513 | $ | 689,785 | |
Source: The Hain Celestial Group, Inc.